Article

Article RDF

pages:

1063 Social vulnerability may underly racial disparities in peripartum cardiomyopathy outcomes Academic Article
11 beta-hydroxylase deficiency in hyperandrogenism. Academic Article
11 Type-2 diabetes leads to improved recovery of myocardial ischemia/reperfusion injury Academic Article
11-beta dehydrogenase type 2 activity is not reduced in treatment resistant hypertension Academic Article
112 “BAND AND LEAVE” STRATEGY: A CASE SERIES COMPARISON OF BANDING VS. ENDOSCOPIC RESECTION FOR MANAGEMENT OF SMALL DUODENAL CARCINOID Academic Article
1120 Assessment of Risk Factors for Mortality With TIPS Placement: Age or Frailty Academic Article
114 Treatment of Bifurcation Aneurysms Using Single Stent-Coiling With Relation to Aneurysm Configuration: A Cohort Study of Two Academic Institutions in the United States. Academic Article
1159 – Reliability of Videoconferencing Pathology in the Interpretation of Barrett's Esophagus Academic Article
116 Gastrointestinal Bleeding Risk in Patients with Ventricular Assist Devices Academic Article
119 Academic Article
11β-Hydroxyandrostenedione and δ⁵-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasia Academic Article
11β-Hydroxysteroid dehydrogenases control access of 7β,27-dihydroxycholesterol to retinoid-related orphan receptor γ Academic Article
12 Intensive care Academic Article
12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels Academic Article
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension the SYMPLICITY HTN-3 trial Academic Article
12/15-Lipoxygenase-dependent ROS production is required for diet-induced endothelial barrier dysfunction Academic Article
13-cis-retinoic acid competitively inhibits 3α-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: A mechanism for its anti-androgenic effects in sebaceous glands? Academic Article
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study Academic Article
130 IN VIVO ANALYSIS OF THE ADENOVIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSE IN CD28-, FASL-, AND PERFORIN-DEFICIENT MICE. Academic Article
13109 Phosphorylation state of Myristoylated Alanine-Rich C-Kinase Substrate Effector Domain mimetics determines its cytotoxicity in glioblastoma and macrophage model Academic Article
133-Xe inhalation method: rCBF indices for total volume flow, normalized flow rate, and tissue volume perfused in acute stroke compared with findings of computer-assisted tomography. Academic Article
136 NOVA primary results randomised controlled study of natalizumab Q6W versus continued Q4W treatment for MS Academic Article
1394 Academic Article
1396 Academic Article
14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease Academic Article
14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model Academic Article
14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model Academic Article
14-3-3 proteins play a role in the cell cycle by shielding Cdt2 from ubiquitin-mediated degradation Academic Article
14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation Academic Article
14-3-3 proteins reduce cell-to-cell transfer and propagation of pathogenic α-synuclein Academic Article

pages: